Crossmark

A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1016/j.htct.2025.103758

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Santos de Macedo, Brunno Gilberto https://orcid.org/0000-0003-2352-6905
Albuquerque de Melo, Manuela https://orcid.org/0000-0002-8413-5396
Pereira-Martins, Diego Antonio https://orcid.org/0000-0002-3302-4311
Machado-Neto, João Agostinho https://orcid.org/0000-0002-2937-8109
Traina, Fabiola https://orcid.org/0000-0003-4258-289X
Funding

Funding for this research was provided by:

State of Sao Paulo Research Foundation (2013/08135-2, 2021/11112-0, 2022/03871-1)

Coordination of Higher Education Personnel Improvement (001, 88887.650052/2021-00)

National Council for Scientific and Technological Development (465539/2014-9, 309614/2022-8, 409401/2021-8)
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-03-15
More Information

This article is maintained by: Elsevier

Article Title: A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2025.103758

Content Type: article

Copyright: © 2025 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.